The global regenerative medicines market size is expected to reach USD 49.41 Billion by 2021, at a CAGR of 23.7% during the forecast period of 2016 to 2021. The market is steadily progressing owing to various factors, such as increasing research in regenerative medicines in the field of orthopaedic musculoskeletal spine and dermatology, investments done by pharmaceutical and biotechnology companies in regenerative medicines especially in cell therapies and immunotherapy, initiatives undertaken by governments, and rapid increase in the need for organ transplantation.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=65442579

Regenerative medicine is one of the new evolving field of research and technology in the market. It can be attained by encouraging the body’s own cells to heal, or by treating a patient with laboratory grown cells and tissues. This field involves a vast network of companies actively involved in biology, chemistry, engineering, and physical sciences. These companies are aggressively developing cell-based therapies, biologics, tissue-engineered cells and materials, and implantable devices.

North America contributed the largest share in the global regenerative medicines market, and was dominated largely by the U.S. Increasing number of organ transplantation and increasing demand of research due to increasing cases in different application areas such as orthopedic musculoskeletal spine, oncology, cardiovascular diseases, and others are driving the U.S. market. Europe is the second-largest market for regenerative medicines with Germany leading the market in the region. The limitations of the global regenerative medicines market are huge investments required in regenerative medicines and lack of experienced professionals in this field.

Major companies operational in the regenerative medicines market are Celgene Corporation (U.S.), Acelity (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), among others.

The research study is aimed at identifying emerging trends and opportunities in the global regenerative medicines market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global regenerative medicines market on the basis of product, therapy, application type, and geography.

Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global regenerative medicines market.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]